A survey of cases of LEMD3-associated skin and bony lesions revealed 28 cases of melorheostosis associated with linear scleroderma, typically affecting skin adjacent to the bone lesions, with a majority of these individuals developing linear (localized) scleroderma in childhood (Table 2). This evidence concerns the gene LEMD3 and melorheostosis.